<qa>  What is the name of the PHASE I STUDY of IXABEPILPHASE I STUDY OF IXABEPILONE PLUS LAPATINIB WITH OR WITHOUT CAPECITABINE IN THE TREATMENT OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 HER2-POSITIVE BREAST CANCER: 